Cargando…

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

N-acetylgalactosaminyl transferase-3 (GalNAc-T3) is an enzyme involved in the initial glycosylation of mucin-type O-linked proteins. In the present study, we used immunohistochemistry to examine GalNAc-T3 expression in 215 surgically resected non-small cell lung cancers. We analysed the biological a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dosaka-Akita, H, Kinoshita, I, Yamazaki, K, Izumi, H, Itoh, T, Katoh, H, Nishimura, M, Matsuo, K, Yamada, Y, Kohno, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364253/ https://www.ncbi.nlm.nih.gov/pubmed/12232759 http://dx.doi.org/10.1038/sj.bjc.6600536

Ejemplares similares

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
por: Gu, C, et al.
Publicado: (2004)

Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas
por: Kitada, S, et al.
Publicado: (2013)

Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers
por: Takimoto, M, et al.
Publicado: (2002)

Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer
por: He, H, et al.
Publicado: (2014)

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein
por: Cui, R, et al.
Publicado: (2003)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage
por: Kurokawa, T, et al.
Publicado: (2003)

Clinical significance of immune cell infiltration within gallbladder cancer
por: Nakakubo, Y, et al.
Publicado: (2003)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma
por: Ebihara, Y, et al.
Publicado: (2004)

Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions-
por: Tajima, Y, et al.
Publicado: (2004)

Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients
por: Azuma, K, et al.
Publicado: (2003)

Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients
por: Shomura, H, et al.
Publicado: (2004)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma
por: Khedhaier, A, et al.
Publicado: (2003)

Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography
por: Chernova, O B, et al.
Publicado: (2003)

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
por: Watson, P H, et al.
Publicado: (2003)

Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients
por: Kubota, T, et al.
Publicado: (2002)

UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
por: Tsuda, N, et al.
Publicado: (2002)

Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24(+) prostate cancer patients
por: Yao, A, et al.
Publicado: (2004)

Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury
por: Takeuchi, Kosei, et al.
Publicado: (2013)

Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT–PCR
por: Sakakura, C, et al.
Publicado: (2004)

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
por: Ichikawa, W, et al.
Publicado: (2003)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells
por: Niizeki, H, et al.
Publicado: (2002)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma
por: Sasamura, H, et al.
Publicado: (2002)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
por: Cooper, R, et al.
Publicado: (2003)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004)

Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes
por: Shin, K-H, et al.
Publicado: (2003)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas
por: Konishi, N, et al.
Publicado: (2003)

Micrometastases in sentinel nodes of gastric cancer
por: Ajisaka, H, et al.
Publicado: (2003)

The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity
por: Mizunuma, H, et al.
Publicado: (2003)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes
por: Mitas, M, et al.
Publicado: (2002)

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
por: Choi, J-H, et al.
Publicado: (2002)

The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma
por: Li, K K C, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_j7kmacn4nhhqs1d8c136h9g75f